HUB Alzheimer Barcelona is a pioneering collaborative initiative rooted in a commitment to transform the future of research and provide support for p1
These findings offer a solid basis for designing clinical trials of therapies aimed at modifying the development of these neurodegenerative diseases1
The study aims to better understand the biological processes that are altered differently in men and women in the early stages of Alzheimer\'s diseas1
Researchers at the Clínic-IDIBAPS led a study published in the Alzheimer’s & Dementia journal on the relationship between the integrity of the locus1
This year, FERO will contribute €200,000, with which it will seek to provide structural and sustained support for the Molecular Diagnostics Programme1
The centre becomes the first in Spain to use blood biomarker p-tau217, which offers a more accurate and less invasive diagnosis and marks a paradigm1
The Minister and the Director of CERCA met with the management of the centre and visited IDIBAPS\' facilities.
The BBVA Foundation – Hospital Clínic de Barcelona Advanced Research Contracts are aimed at specialists in the Health Sciences, with experience in re1
Researchers at the Hospital Clínic-IDIBAPS are leading a study that shows that participating in professional football as an occupation is a factor th1
Gene therapy applied to the treatment of neurodegenerative diseases is a promising field of study, and consists of modifying a patient\'s genes to sl1
